A review of the current understanding and clinical utility of miRNAs in esophageal cancer.
Semin Cancer Biol
; 23(6 Pt B): 512-21, 2013 Dec.
Article
em En
| MEDLINE
| ID: mdl-24013023
Palavras-chave
5-FU; 5-fluorouracil; B cell lymphoma 2; BE; Barrett's esophagus; Bcl-2; Biomarkers; CD47; CDH1; Cluster of differentiation 47; DGCR8; DICER1; Diagnosis; E-Cadherin; EAC; ESCC; Esophageal adenocarcinoma; Esophageal squamous cell carcinoma; F box/WD repeat containing protein 7; FBXW7; FSCN1; HGD; High grade dysplasia; IGF1R; IRS; Insulin like growth factor receptor 1; LATS2; LDHB; LGD; LNM; Low grade dysplasia; Lymph node metastasis; MDR1; MISH; MicroRNA; MicroRNA [ribonucleic acid]; NE; Normal epithelium; Oesophageal cancer; P27; PPP2R1B; Pasha protein; Prognosis; Protein 53; Quantitative reverse transcription polymerase chain reaction; RNA; RNASEN; Rap1a; Rap1b; Ras related protein 1a; Ras related protein 1b; Ribonuclease 3 enzyme gene; ascin homolog 1, actin bundling protein; endoribonuclease of RNase III family; inflammatory risk score; lactate dehydrogenase B; large tumor suppressor, homolog 2; miRNA in situ hybridization; miRNA/miR; multi drug resistance 1; p53; protein 27; protein phosphatase 2 regulatory subunit beta isoform; qRT-PCR; ribonucleic acid
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Esofágicas
/
MicroRNAs
Tipo de estudo:
Diagnostic_studies
/
Prognostic_studies
Limite:
Animals
/
Humans
Idioma:
En
Ano de publicação:
2013
Tipo de documento:
Article